20 May 2026
Structural heart devices: what's new and how it reaches your cathlab
Anchorperson:
R. Parma
Spokesperson:
N. Karam
Summary
Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of success and challenges in device development.
Learning Objectives
- To discover the latest structural heart device innovations, from new TAVR platforms and leaflet modification to next-gen mitral/tricuspid technologies and closure devices, and assess their clinical readiness
- To understand how a structural heart device travels from concept to your cath lab: the innovation pathway through prototyping, first-in-human studies, regulatory clearance (FDA Breakthrough, EU MDR), and market adoption
- To learn from physician-innovators who have lived the journey, what drives success, what kills promising devices, and how you can engage with the innovation ecosystem as inventor, investigator, or early adopter
